PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study-Reference-Cited by-同舟云学术

PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study

Published:2022-12-17 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Kocabaş Umut^ORCID,Ergin Isil^ORCID,Yavuz Veysel^ORCID,Murat Selda^ORCID,Özdemir Ibrahim^ORCID,Genç Ömer^ORCID,Altın Cihan^ORCID,Tüner Haşim^ORCID,Meriç Bengisu Keskin^ORCID,Çoner Ali^ORCID,Yüce Elif İlkay^ORCID,Boyraz Bedrettin^ORCID,Aslan Onur^ORCID,Dal Ahmet^ORCID,Şen Taner^ORCID,İbişoğlu Ersin^ORCID,Erdoğan Aslan^ORCID,Özgeyik Mehmet^ORCID,Demir Mevlüt^ORCID,Bilgel Ziya Gökalp^ORCID,Şengör Büşra Güvendi^ORCID,Urgun Örsan Deniz^ORCID,Doğduş Mustafa^ORCID,Tekin Deniz Dilan Naki^ORCID,Çakal Sinem^ORCID,Çayırlı Sercan^ORCID,Güler Arda^ORCID,Karabulut Dilay^ORCID,Dalgıç Onur^ORCID,Uzman Osman^ORCID,Murat Bektaş^ORCID,Şahin Şeyda^ORCID,Karabulut Umut^ORCID,Kıvrak Tarık^ORCID,Coşgun Muharrem Said^ORCID,Özyurtlu Ferhat^ORCID,Kaplan Mehmet^ORCID,Özçalık Emre^ORCID,Uzun Hakan Gökalp,Kalaycı Süleyman,Bingöl Gülsüm,Özden Özge,Öztekin Gülsüm Meral Yılmaz,Gümüşdağ Ayça,Altınsoy Meltem,Aydınyılmaz Faruk,Yeni Mehtap,Biter Halil İbrahim,Sinan Ümit Yaşar,Barış Veysel Özgür,Vuran Özcan,Okar Sefa,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-022-07409-w.pdf

Reference30 articles.

1. Hindricks G, Potpara T, Dagres N, ESC Scientific Document Group, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.

2. Kocabas U, Kaya E, Avcı G. Novel oral anticoagulants in non-valvular atrial fibrillation: pharmacological properties, clinical trials, guideline recommendations, new antidote drugs and real-world data. Int J Cardiovasc Acad. 2016;2:167–73.

3. Connolly SJ, Ezekowitz MD, Yusuf S, RE-LY Steering Committee Investigators, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:11391151.

4. Patel MR, Mahaffey KW, Garg J, ROCKET AF Investigators, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883891.

5. Granger CB, Alexander JH, McMurray JJ, et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981992.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial Fibrillation Management in Acute Stroke Patients in Türkiye: Real-life Data from the NöroTek Study;Turkish Journal Of Neurology;2023-10-02

2. Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study;Cardiovascular Drugs and Therapy;2023-01-19

3. Real-World Data on the Incidence of Stroke, Myocardial Infarction, and Mortality Among Nonvalvular Atrial Fibrillation Patients in Türkiye: New Oral Anticoagulants-TURKey Study;The Anatolian Journal of Cardiology;2023